Loading…

Regulatory and pathogenetic mechanisms of autoantibodies in SLE

In the 53 years since the discovery of anti-DNA autoantibodies in lupus [1, 2, 3], recalcitrant questions have been pondered and possible answers have been debated. The discovery of anti-DNA autoantibodies presented many puzzles: How is immunological tolerance to native B-form DNA broken? What elici...

Full description

Saved in:
Bibliographic Details
Published in:Autoimmunity (Chur, Switzerland) Switzerland), 2011-08, Vol.44 (5), p.349-356
Main Authors: Radic, Marko, Herrmann, Martin, van der Vlag, Johan, Rekvig, Ole Petter
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c450t-dd616c16494bbaead09cc16b3d805f53f5a8d21c48be3f1f0cfec03b57fac5dc3
cites cdi_FETCH-LOGICAL-c450t-dd616c16494bbaead09cc16b3d805f53f5a8d21c48be3f1f0cfec03b57fac5dc3
container_end_page 356
container_issue 5
container_start_page 349
container_title Autoimmunity (Chur, Switzerland)
container_volume 44
creator Radic, Marko
Herrmann, Martin
van der Vlag, Johan
Rekvig, Ole Petter
description In the 53 years since the discovery of anti-DNA autoantibodies in lupus [1, 2, 3], recalcitrant questions have been pondered and possible answers have been debated. The discovery of anti-DNA autoantibodies presented many puzzles: How is immunological tolerance to native B-form DNA broken? What elicits characteristic systemic lupus erythematosus (SLE) autoantibodies? Which of the diverse anti-nuclear reactivities are pathogenic? What is the role of autoantibodies in the clinical presentation of disease? How do genetic predisposition and environmental triggers contribute to SLE? These questions were brought into focus by Professor David Stollar in an introductory presentation to an intense, three-day meeting set among the rugged and inspiring scenery of the Norwegian arctic coastline (the Scientific Program is included as supplemental File 1). Other participants presented and discussed topics directed to understanding the origin and clinico-pathological impact of autoantibodies to chromatin and phospholipid antigens. In the following, several aspects of the workshop are discussed.
doi_str_mv 10.3109/08916934.2010.536794
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1367494652</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>875723439</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-dd616c16494bbaead09cc16b3d805f53f5a8d21c48be3f1f0cfec03b57fac5dc3</originalsourceid><addsrcrecordid>eNp9kE1rGzEQhkVJaByn_6CUvaWXTaSVtB-XhmDSNGAIpA30Jmb1ESvsSq6kpfjfV4vjQi4-DRo9887wIPSZ4CtKcHeN247UHWVXFc4tTuumYx_QgtS4KVtW_T5BixkpZ-YMncf4ijGumpp9RGcVqSjJnwt086RfpgGSD7sCnCq2kDb-RTudrCxGLTfgbBxj4U0BU_Lgku29sjoW1hU_13cX6NTAEPWnt7pEz9_vfq1-lOvH-4fV7bqUjONUKlWTWpKadazvQYPCnczPnqoWc8Op4dCqikjW9poaYrA0WmLa88aA5ErSJbrc526D_zPpmMRoo9TDAE77KYq24U1FGe0y-fUoSbKpfEbNq4yyPSqDjzFoI7bBjhB2gmAxSxYHyWKWLPaS89iXtw1TP2r1f-hgNQM3e8A648MIf30YlEiwG3wwAZy0cY4_uuLbu4SNhiFtJAQtXv0UXFZ9_MZ_15qfWw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1367494652</pqid></control><display><type>article</type><title>Regulatory and pathogenetic mechanisms of autoantibodies in SLE</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Radic, Marko ; Herrmann, Martin ; van der Vlag, Johan ; Rekvig, Ole Petter</creator><creatorcontrib>Radic, Marko ; Herrmann, Martin ; van der Vlag, Johan ; Rekvig, Ole Petter</creatorcontrib><description>In the 53 years since the discovery of anti-DNA autoantibodies in lupus [1, 2, 3], recalcitrant questions have been pondered and possible answers have been debated. The discovery of anti-DNA autoantibodies presented many puzzles: How is immunological tolerance to native B-form DNA broken? What elicits characteristic systemic lupus erythematosus (SLE) autoantibodies? Which of the diverse anti-nuclear reactivities are pathogenic? What is the role of autoantibodies in the clinical presentation of disease? How do genetic predisposition and environmental triggers contribute to SLE? These questions were brought into focus by Professor David Stollar in an introductory presentation to an intense, three-day meeting set among the rugged and inspiring scenery of the Norwegian arctic coastline (the Scientific Program is included as supplemental File 1). Other participants presented and discussed topics directed to understanding the origin and clinico-pathological impact of autoantibodies to chromatin and phospholipid antigens. In the following, several aspects of the workshop are discussed.</description><identifier>ISSN: 0891-6934</identifier><identifier>EISSN: 1607-842X</identifier><identifier>DOI: 10.3109/08916934.2010.536794</identifier><identifier>PMID: 21231891</identifier><language>eng</language><publisher>England: Informa Healthcare</publisher><subject>Animals ; Animals, Genetically Modified ; anti-DNA antibodies ; Antibodies, Antinuclear - immunology ; Antibodies, Antinuclear - metabolism ; apoptosis ; autoantibodies ; Autoantigens - immunology ; B cell regulation ; B-Lymphocytes - cytology ; B-Lymphocytes - immunology ; B-Lymphocytes - metabolism ; Cell Death - immunology ; Disease Models, Animal ; Glomerulonephritis - etiology ; Glomerulonephritis - immunology ; Glomerulonephritis - metabolism ; Humans ; Lupus Erythematosus, Systemic - complications ; Lupus Erythematosus, Systemic - genetics ; Lupus Erythematosus, Systemic - immunology ; Lupus Erythematosus, Systemic - therapy ; Mice ; Systemic lupus erythematosus</subject><ispartof>Autoimmunity (Chur, Switzerland), 2011-08, Vol.44 (5), p.349-356</ispartof><rights>Informa UK, Ltd. 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-dd616c16494bbaead09cc16b3d805f53f5a8d21c48be3f1f0cfec03b57fac5dc3</citedby><cites>FETCH-LOGICAL-c450t-dd616c16494bbaead09cc16b3d805f53f5a8d21c48be3f1f0cfec03b57fac5dc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21231891$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Radic, Marko</creatorcontrib><creatorcontrib>Herrmann, Martin</creatorcontrib><creatorcontrib>van der Vlag, Johan</creatorcontrib><creatorcontrib>Rekvig, Ole Petter</creatorcontrib><title>Regulatory and pathogenetic mechanisms of autoantibodies in SLE</title><title>Autoimmunity (Chur, Switzerland)</title><addtitle>Autoimmunity</addtitle><description>In the 53 years since the discovery of anti-DNA autoantibodies in lupus [1, 2, 3], recalcitrant questions have been pondered and possible answers have been debated. The discovery of anti-DNA autoantibodies presented many puzzles: How is immunological tolerance to native B-form DNA broken? What elicits characteristic systemic lupus erythematosus (SLE) autoantibodies? Which of the diverse anti-nuclear reactivities are pathogenic? What is the role of autoantibodies in the clinical presentation of disease? How do genetic predisposition and environmental triggers contribute to SLE? These questions were brought into focus by Professor David Stollar in an introductory presentation to an intense, three-day meeting set among the rugged and inspiring scenery of the Norwegian arctic coastline (the Scientific Program is included as supplemental File 1). Other participants presented and discussed topics directed to understanding the origin and clinico-pathological impact of autoantibodies to chromatin and phospholipid antigens. In the following, several aspects of the workshop are discussed.</description><subject>Animals</subject><subject>Animals, Genetically Modified</subject><subject>anti-DNA antibodies</subject><subject>Antibodies, Antinuclear - immunology</subject><subject>Antibodies, Antinuclear - metabolism</subject><subject>apoptosis</subject><subject>autoantibodies</subject><subject>Autoantigens - immunology</subject><subject>B cell regulation</subject><subject>B-Lymphocytes - cytology</subject><subject>B-Lymphocytes - immunology</subject><subject>B-Lymphocytes - metabolism</subject><subject>Cell Death - immunology</subject><subject>Disease Models, Animal</subject><subject>Glomerulonephritis - etiology</subject><subject>Glomerulonephritis - immunology</subject><subject>Glomerulonephritis - metabolism</subject><subject>Humans</subject><subject>Lupus Erythematosus, Systemic - complications</subject><subject>Lupus Erythematosus, Systemic - genetics</subject><subject>Lupus Erythematosus, Systemic - immunology</subject><subject>Lupus Erythematosus, Systemic - therapy</subject><subject>Mice</subject><subject>Systemic lupus erythematosus</subject><issn>0891-6934</issn><issn>1607-842X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNp9kE1rGzEQhkVJaByn_6CUvaWXTaSVtB-XhmDSNGAIpA30Jmb1ESvsSq6kpfjfV4vjQi4-DRo9887wIPSZ4CtKcHeN247UHWVXFc4tTuumYx_QgtS4KVtW_T5BixkpZ-YMncf4ijGumpp9RGcVqSjJnwt086RfpgGSD7sCnCq2kDb-RTudrCxGLTfgbBxj4U0BU_Lgku29sjoW1hU_13cX6NTAEPWnt7pEz9_vfq1-lOvH-4fV7bqUjONUKlWTWpKadazvQYPCnczPnqoWc8Op4dCqikjW9poaYrA0WmLa88aA5ErSJbrc526D_zPpmMRoo9TDAE77KYq24U1FGe0y-fUoSbKpfEbNq4yyPSqDjzFoI7bBjhB2gmAxSxYHyWKWLPaS89iXtw1TP2r1f-hgNQM3e8A648MIf30YlEiwG3wwAZy0cY4_uuLbu4SNhiFtJAQtXv0UXFZ9_MZ_15qfWw</recordid><startdate>201108</startdate><enddate>201108</enddate><creator>Radic, Marko</creator><creator>Herrmann, Martin</creator><creator>van der Vlag, Johan</creator><creator>Rekvig, Ole Petter</creator><general>Informa Healthcare</general><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>201108</creationdate><title>Regulatory and pathogenetic mechanisms of autoantibodies in SLE</title><author>Radic, Marko ; Herrmann, Martin ; van der Vlag, Johan ; Rekvig, Ole Petter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-dd616c16494bbaead09cc16b3d805f53f5a8d21c48be3f1f0cfec03b57fac5dc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Animals, Genetically Modified</topic><topic>anti-DNA antibodies</topic><topic>Antibodies, Antinuclear - immunology</topic><topic>Antibodies, Antinuclear - metabolism</topic><topic>apoptosis</topic><topic>autoantibodies</topic><topic>Autoantigens - immunology</topic><topic>B cell regulation</topic><topic>B-Lymphocytes - cytology</topic><topic>B-Lymphocytes - immunology</topic><topic>B-Lymphocytes - metabolism</topic><topic>Cell Death - immunology</topic><topic>Disease Models, Animal</topic><topic>Glomerulonephritis - etiology</topic><topic>Glomerulonephritis - immunology</topic><topic>Glomerulonephritis - metabolism</topic><topic>Humans</topic><topic>Lupus Erythematosus, Systemic - complications</topic><topic>Lupus Erythematosus, Systemic - genetics</topic><topic>Lupus Erythematosus, Systemic - immunology</topic><topic>Lupus Erythematosus, Systemic - therapy</topic><topic>Mice</topic><topic>Systemic lupus erythematosus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Radic, Marko</creatorcontrib><creatorcontrib>Herrmann, Martin</creatorcontrib><creatorcontrib>van der Vlag, Johan</creatorcontrib><creatorcontrib>Rekvig, Ole Petter</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Autoimmunity (Chur, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Radic, Marko</au><au>Herrmann, Martin</au><au>van der Vlag, Johan</au><au>Rekvig, Ole Petter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulatory and pathogenetic mechanisms of autoantibodies in SLE</atitle><jtitle>Autoimmunity (Chur, Switzerland)</jtitle><addtitle>Autoimmunity</addtitle><date>2011-08</date><risdate>2011</risdate><volume>44</volume><issue>5</issue><spage>349</spage><epage>356</epage><pages>349-356</pages><issn>0891-6934</issn><eissn>1607-842X</eissn><abstract>In the 53 years since the discovery of anti-DNA autoantibodies in lupus [1, 2, 3], recalcitrant questions have been pondered and possible answers have been debated. The discovery of anti-DNA autoantibodies presented many puzzles: How is immunological tolerance to native B-form DNA broken? What elicits characteristic systemic lupus erythematosus (SLE) autoantibodies? Which of the diverse anti-nuclear reactivities are pathogenic? What is the role of autoantibodies in the clinical presentation of disease? How do genetic predisposition and environmental triggers contribute to SLE? These questions were brought into focus by Professor David Stollar in an introductory presentation to an intense, three-day meeting set among the rugged and inspiring scenery of the Norwegian arctic coastline (the Scientific Program is included as supplemental File 1). Other participants presented and discussed topics directed to understanding the origin and clinico-pathological impact of autoantibodies to chromatin and phospholipid antigens. In the following, several aspects of the workshop are discussed.</abstract><cop>England</cop><pub>Informa Healthcare</pub><pmid>21231891</pmid><doi>10.3109/08916934.2010.536794</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0891-6934
ispartof Autoimmunity (Chur, Switzerland), 2011-08, Vol.44 (5), p.349-356
issn 0891-6934
1607-842X
language eng
recordid cdi_proquest_miscellaneous_1367494652
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Animals
Animals, Genetically Modified
anti-DNA antibodies
Antibodies, Antinuclear - immunology
Antibodies, Antinuclear - metabolism
apoptosis
autoantibodies
Autoantigens - immunology
B cell regulation
B-Lymphocytes - cytology
B-Lymphocytes - immunology
B-Lymphocytes - metabolism
Cell Death - immunology
Disease Models, Animal
Glomerulonephritis - etiology
Glomerulonephritis - immunology
Glomerulonephritis - metabolism
Humans
Lupus Erythematosus, Systemic - complications
Lupus Erythematosus, Systemic - genetics
Lupus Erythematosus, Systemic - immunology
Lupus Erythematosus, Systemic - therapy
Mice
Systemic lupus erythematosus
title Regulatory and pathogenetic mechanisms of autoantibodies in SLE
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A57%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulatory%20and%20pathogenetic%20mechanisms%20of%20autoantibodies%20in%20SLE&rft.jtitle=Autoimmunity%20(Chur,%20Switzerland)&rft.au=Radic,%20Marko&rft.date=2011-08&rft.volume=44&rft.issue=5&rft.spage=349&rft.epage=356&rft.pages=349-356&rft.issn=0891-6934&rft.eissn=1607-842X&rft_id=info:doi/10.3109/08916934.2010.536794&rft_dat=%3Cproquest_cross%3E875723439%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c450t-dd616c16494bbaead09cc16b3d805f53f5a8d21c48be3f1f0cfec03b57fac5dc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1367494652&rft_id=info:pmid/21231891&rfr_iscdi=true